Primary adenosine monophosphate (AMP) deaminase deficiency in a hypotonic infant

J Child Neurol. 2011 Jun;26(6):734-7. doi: 10.1177/0883073810390367. Epub 2011 Feb 22.

Abstract

The spectrum of the adenosine monophosphate (AMP) deaminase deficiency ranges from asymptomatic carriers to patients who manifest exercise-induced muscle pain, occasionally rhabdomyolysis, and idiopathic hyperCKemia. However, previous to the introduction of molecular techniques, rare cases with congenital weakness and hypotonia have also been reported. We report a 6-month-old girl with the association of congenital muscle weakness and hypotonia, muscle deficiency of adenosine monophosphate deaminase, and the homozygous C to T mutation at nucleotide 34 of the adenosine monophosphate deaminase-1 gene. This observation indicates the possible existence of a primary adenosine monophosphate deaminase deficiency manifested by congenital muscle weakness and hypotonia.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP Deaminase / deficiency*
  • Female
  • Humans
  • Infant
  • Muscle Hypotonia / complications
  • Muscle Hypotonia / genetics*
  • Muscle Hypotonia / pathology
  • Muscle Weakness / complications
  • Muscle Weakness / genetics
  • Muscle, Skeletal / enzymology
  • Mutation / genetics

Substances

  • AMP Deaminase